MedPath

Investigating a digital device to increase the efficiency of trauma-focused psychotherapy in PTSD patients: a pilot randomized controlled trial of the EMD app.

Completed
Conditions
posttraumatic stress disorder
PTSD
10002861
Registration Number
NL-OMON47137
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
57
Inclusion Criteria

- 18 * 65 years of age or older
- Referred to a mental health care organisation for PTSD following one or more traumatic experiences
- Meet the DSM-5 diagnostic criteria for PTSD as confirmed by the CAPS-5
- Are in possession of a device such as a laptop, tablet, mobile phone or computer
- Have sufficient command of the Dutch language, both verbally and in writing
- Provide signed informed consent

Exclusion Criteria

- Having current high risk for suicide according to the M.I.N.I. Interview for psychiatric disorders, section C
- Having serious psychiatric co-morbidity i.e. bipolar affective disorder, psychotic disorder, substance dependence that would interfere with EMDR treatment as assessed by the therapist in the intake.
- Being unable to comprehend the spoken and written Dutch language.
- Not having access to a computer, laptop, tablet or smartphone with an internet connection.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome parameter is the difference in PTSD symptom severity<br /><br>response pattern during the five sessions between the EMDR + EMD app group as<br /><br>compared to the EMDR alone group. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes include depressive symptoms, general anxiety symptoms,<br /><br>acceptability, usability and client satisfaction.</p><br>
© Copyright 2025. All Rights Reserved by MedPath